comparemela.com

Latest Breaking News On - Akthelia pharma - Page 1 : comparemela.com

Antibiotic Resistance Markets Therapeutics, by Pathogen and

Dublin, May 27, 2024 (GLOBE NEWSWIRE) The

Iceland
Dublin
Ireland
Theravance-biopharma
Procarta-biosystems
Ampliphi-biosciences
Eligo-bioscience
Johnson-janssen
Bioversys-gmb
Biofilm-pharma
Akthelia-pharma
Absynth-biologics

Global Antibiotic Resistance Market Research Report 2023-2027: Search for Alternatives to Antibiotics Creates New Goldrush

/PRNewswire/ The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides &.

Dublin
Ireland
Iceland
United-states
Akthelia-pharma
Xellia-pharmaceutials
Qpex-biopharma
Redhill-biopharma
Biofilm-pharma
Theravance-biopharma
Procarta-biosystems
Absynth-biologics

Global Antibiotic Resistance Markets, 2023-2027: Beyond

Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) The

Dublin
Ireland
Iceland
United-states
Qpex-biopharma
Xellia-pharmaceutials
Procarta-biosystems
Biofilm-pharma
Johnson-janssen
Theravance-biopharma
Absynth-biologics
Bioversys-gmb

Icelandic deep tech startup and the University of Iceland secure a €6M EU Horizon grant to combat antimicrobial resistance (AMR)

Reykjavik-based biopharma startup Akthelia Pharmaceuticals and the University of Iceland have been awarded a €6 million EU Horizon Grant to fund the IN-ARMOR

Iceland
Reykjavik
C10
Egill-masson
Gudmundur-gudmundsson
Akthelia-pharma
University-of-iceland
Akthelia-pharmaceuticals
Professor-gudmundur-gudmundsson
Cell-biology

Akthelia, University of Iceland receive funds for IN-ARMOR project

Akthelia Pharmaceuticals, along with the University of Iceland, has received a €6m EU Horizon Grant for the IN-ARMOR project.

Iceland
Egill-masson
Gerd-altmann
Akthelia-pharma
Akthelia-pharmaceuticals
European-union-eu-horizon-grant
World-health-organisation
University-of-iceland
European-union
Horizon-grant

vimarsana © 2020. All Rights Reserved.